AI Solutions for Clinic Waiting Rooms (CEO Video Breakdown) In this Medbright AI Investments (Ticker: MBAI.c or MBAIF for US investors) video, CEO Trevor Vieweg and Chairman Dr. Jamie Gerber shed light on their groundbreaking approach to healthcare investment. Operating at the intersection of healthcare and technology, MBAI.c is on a mission to leverage artificial intelligence (AI) for the betterment of patient and physician experiences.
Tackling what they term the "waiting room problem", MBAI.c has strategically invested in companies working collaboratively to develop an AI-powered solution: MedMatrix, an AI-powered data analytics platform and engine, is the innovative solution that MBAI.c believes will reshape clinic operations.
The waiting room problem happens across healthcare settings and, as Dr. Gerber points out, is 3-fold: getting an appointment, navigating through the office, and ensuring adequate follow-up care.
Inefficiencies in these 3 steps are so costly that MBAI believes the market opportunity for this tech is $200B.
By evaluating various factors related to a patient's background, clinical history, and other pertinent information, MBAI's Medmatrix predicts resource needs for upcoming visits.
While traditional rigid 15-minute time slots often fall short accommodating the unique needs of diverse patients, this approach not only reduces physician burnout but also enhances the quality of care provided to patients.
This predictive model then optimizes provider schedules without requiring new software or extensive staff training. This is expected to increase clinic revenue by 10% at no extra cost to providers.
Dr. Gerber sees MedMatrix as a tool that addresses three major challenges for clinics and doctors: reducing physician burnout, enhancing the quality of care, and creating new revenue opportunities.
By better aligning physician resources with patient needs, Med Matrix contributes to improved patient satisfaction, increased physician engagement, and a more robust bottom line for clinics.
Full video here:
Posted on behalf of Medbright AI Investments Inc.